脑部放疗,上午比下午敏感许多!
$ m( r V, T8 Q9 M0 v) v
4 E3 v& ~9 T$ U% C9 n$ _+ o# p z' H7 N% \% F: R/ {
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.3 v8 L: K. X a) u$ ~
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
$ m" Q7 M8 p& w4 I+ KRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
: N' j9 l- r7 k8 G% t$ PSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
! W/ y% b) j- y0 Y( f6 H5 s/ g; U
: q0 `' S6 D+ ~Abstract& i2 z" R$ q. K! s8 a4 ], l8 T
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
h& g- Q; e2 J' l) l2 I, C! h! v; `1 w/ H# I) f0 F
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.0 R0 q/ ?) N3 w( }9 t
) `7 q: d- @+ {2 K& m6 X% ]2 E
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).' x# c- Y! o8 f, k5 e4 G; w
- Y( q- ?5 A2 V- xCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series." q: S6 U- n1 h4 `) t
5 Q7 z( Z' O9 M/ D4 e% O, X9 ?+ d
|